AMBOSS Acquires NEJM Knowledge+ From NEJM Group, Setting a New Standard in Medical Education and Clinical Practice
AMBOSS Acquires NEJM Knowledge+ From NEJM Group, Setting a New Standard in Medical Education and Clinical Practice
BOSTON, April 25, 2024 /PRNewswire/ -- AMBOSS, the leading clinical resource for residents, proudly announces its recent acquisition of NEJM Knowledge+, a learning and assessment tool for clinicians created by NEJM Group, publishers of the New England Journal of Medicine and other prominent medical resources for physicians and other health professionals. This marks a significant milestone for AMBOSS and for the practice of evidence-based medicine worldwide.
波士顿，2024年4月25日 /PRNewswire/ — 领先的住院医师临床资源AMBOSS自豪地宣布最近收购了NEJM Knowledge+，这是一款由该出版商NEJM集团为临床医生开发的学习和评估工具 新英格兰医学杂志 以及为医生和其他卫生专业人员提供的其他重要医疗资源。这对于AMBOSS和全球循证医学实践来说是一个重要的里程碑。
Integrating NEJM Knowledge+ with AMBOSS's clinical decision support tool offers an unparalleled resource for modern healthcare professionals who expect easily accessible and actionable medical information to build their knowledge base and drive clinical decision-making throughout their career — from medical school through clinical practice.
将NEJM Knowledge+与AMBOSS的临床决策支持工具相结合，为现代医疗保健专业人员提供了无与伦比的资源，他们期望从医学院到临床实践的整个职业生涯中都能建立知识库并推动临床决策。
With this acquisition NEJM Group and AMBOSS reaffirm their commitment to enhancing medical education & clinical practice
通过此次收购，NEJM集团和AMBOSS重申了他们对加强医学教育和临床实践的承诺
Empowering the Next Generation of Healthcare Professionals
赋予下一代医疗保健专业人员权力
AMBOSS is renowned for its expert medical library, intuitive learning platform, and user interface designed to easily obtain and retain medical knowledge. Already an established leader of knowledge platforms in US medical schools and used by the majority of medical students, AMBOSS is now transforming residency, with 25% of first-year US residents relying on it to provide excellent patient care. The acquisition of NEJM Knowledge+ is a leap forward in realizing the vision of a fully integrated platform where board exam preparation and clinical practice converge seamlessly.
大放异彩的 以其专业的医学图书馆、直观的学习平台和旨在轻松获取和保留医学知识的用户界面而闻名。AMBOSS已经是美国医学院知识平台的知名领导者，并被大多数医学生使用。现在，AMBOSS正在改变居留方式，25％的美国一年级居民依赖它来提供优质的患者护理。收购NEJM Knowledge+是在实现董事会考试准备和临床实践无缝融合的完全集成平台愿景方面向前迈出的飞跃。
"We are really excited to bring NEJM Knowledge+ into the AMBOSS family," said Dr. Madjid Salimi, Co-Founder and Co-CEO of AMBOSS. "It's an honor to have the confidence of NEJM Group leadership in our ability to build on their success in providing exceptional educational resources for clinicians."
AMBOSS联合创始人兼联席首席执行官马吉德·萨利米博士说：“我们非常高兴将NEJM Knowledge+带入AMBOSS大家庭。“很荣幸NEJM集团领导层相信我们有能力在他们成功为临床医生提供卓越教育资源的基础上再接再厉。”
A Unified Vision for the Future of Clinical Training
对未来临床培训的统一愿景
NEJM Group has been recognized as the global leader in the creation and distribution of the latest and highest quality medical information. In 2014, they released NEJM Knowledge+, an adaptive-learning board preparation question bank that is now trusted by over 500 residency programs in Internal Medicine, Family Medicine, and Pediatrics.
NEJM 集团被公认为创建和发布最新、最高质量的医疗信息的全球领导者。2014年，他们发布了NEJM Knowledge+，这是一个自适应学习委员会备考问题库，现在受到内科、家庭医学和儿科500多个住院医师项目的信任。
"NEJM Group has always been at the forefront of disseminating medical knowledge and improving patient care," said David Sampson, Vice President, Chief Publishing Officer of NEJM Group. "This new chapter is a natural progression of our mission, with AMBOSS being ideally positioned to expand the reach of NEJM Knowledge+."
NEJM集团副总裁兼首席出版官戴维·桑普森说：“NEJM集团一直站在传播医学知识和改善患者护理的最前沿。”“这一新篇章是我们使命的自然进展，AMBOSS处于扩大NEJM Knowledge+覆盖范围的理想位置。”
Looking Ahead
展望未来
Through this acquisition, AMBOSS and NEJM Group reaffirm their commitment to enhancing medical education and clinical practice. Healthcare professionals and students can look forward to benefiting from an all-encompassing platform that offers personalized learning experiences and point-of-care clinical knowledge designed to support their journey at every stage.
通过此次收购，AMBOSS和NEJM集团重申了他们对加强医学教育和临床实践的承诺。医疗保健专业人员和学生可以期待从一个无所不包的平台中受益，该平台提供个性化的学习体验和即时临床知识，旨在为他们的每个阶段的旅程提供支持。
For more information about AMBOSS and NEJM Knowledge+, please visit us here.
有关 AMBOSS 和 NEJM Knowledge+ 的更多信息，请访问我们 这里。
About AMBOSS
关于 AMBOSS
Founded in 2012 by a team of physicians, AMBOSS is a global medical knowledge platform that has fundamentally changed the way medical know-how is acquired and utilized at the point of care. With an emphasis on high-quality content, innovative technology, and a user-centered approach, the company has grown its international team to over 500 physicians, scientists, and software engineers. AMBOSS counts more than 1 million users across 170 countries. For more information, visit
AMBOSS 由一组医师于 2012 年创立，是一个全球医学知识平台，它从根本上改变了在护理点获取和使用医疗知识的方式。该公司注重高质量内容、创新技术和以用户为中心的方法，已将其国际团队发展到500多名医生、科学家和软件工程师。AMBOSS 在 170 个国家拥有超过 100 万用户。欲了解更多信息，请访问
About NEJM Group
关于 NEJM 集团
NEJM Group creates high-quality medical resources for research, learning, practice and professional development designed to meet the demand for essential medical knowledge among academic researchers and teachers, physicians, clinicians, executives and others in medicine and health care. NEJM Group products include the New England Journal of Medicine, NEJM Evidence, NEJM AI, NEJM Catalyst, NEJM Journal Watch, NEJM Resident 360, NEJM Yi Xue Qian Yan and NEJM Career Center. NEJM Group is a division of the Massachusetts Medical Society. For more information visit .
NEJM 集团为研究、学习、实践和专业发展创造高质量的医疗资源，旨在满足学术研究人员和教师、医生、临床医生、高管和其他医学和医疗保健领域对基本医学知识的需求。NEJM 集团的产品包括 新英格兰医学杂志、NEJM 证据、NEJM AI、NEJM Catalyst、NEJM Journal Watch、NEJM Resident 360、NEJM Yi Xue Qian Yan 和 NEJM 职业中心。NEJM 集团是马萨诸塞州医学会的一个分支机构。欲了解更多信息，请访问 。
SOURCE AMBOSS
来源 AMBOSS
译文内容由第三方软件翻译。